|
ABBS publishes papers
based on original research that are judged, after editorial
review, to make a novel and important contribution to the
understanding of any area of biochemistry, biophysics,
molecular biology or cell biology. Manuscripts may be submitted
for consideration as regular papers. ABBS also publishes
reviews, most of which are by invitation only.
It is the responsibility of the
Editor-in-Chief, the Editors, and the Editorial Board to
determine the suitability of a manuscript for publication. After
receipt of a manuscript by the Administrator, it is checked for
suitability and then sent to the Editor-in-Chief who
usually assigns it to a member of the Editorial Board. The Board
member then invite reviewers and makes a recommendation for
acceptance, revision, or declination based on the scientific
merit and technical quality of the studies reported and the
reviewers' comments and suggestions.
All Board members and reviewers who review a
manuscript remain unknown to the authors. Every manuscript is
treated by the editors and reviewers as privileged information,
and they are instructed to exclude themselves from review of any
manuscript that might involve a conflict of interest or the
appearance thereof.
The primary criteria for judging the
acceptability of a manuscript are its novelty and scientific
importance. Manuscripts judged lacking in these respects will be
declined, even if the experimental work appears technically
sound. This policy permits declination of a manuscript solely on
the Editorial Board' s judgment that the studies reported are
not sufficiently novel or important to merit publication in
ABBS.
As a condition of publication, all authors
must transfer copyright to Insitute of Biochemistry and Cell
Biology. Manuscripts submitted under multiple authorship are
reviewed on the assumption that all listed authors concur in the
submission and that the final version of the manuscript has been
seen and approved by all authors. |
